Attenuation of oxidative stress-induced lesions in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia and atherosclerosis through the inhibition of Nox2 activity
Attenuation of oxidative stress-induced lesions in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia and atherosclerosis through the inhibition of Nox2 activity
Obesity leading to hyperlipidaemia and atherosclerosis is recognised to induce morphological and metabolic changes in many tissues. However, hyperlipidaemia can occur in the absence of obesity. The impact of the latter scenario on skeletal muscle and liver is not understood sufficiently. In this regard, we used the Apolipoprotein E-deficient (ApoE-/-) mouse model, an established model of hyperlipidaemia and atherosclerosis, that does not become obese when subjected to a high-fat diet, to determine the impact of Western-type diet (WD) and ApoE deficiency on skeletal muscle morphological, metabolic and biochemical properties. To establish the potential of therapeutic targets, we further examined the impact of Nox2 pharmacological inhibition on skeletal muscle redox biology. We found ectopic lipid accumulation in skeletal muscle and the liver, and altered skeletal muscle morphology and intramuscular triacylglycerol fatty acid composition. WD and ApoE deficiency had a detrimental impact in muscle metabolome, followed by perturbed gene expression for fatty acid uptake and oxidation. Importantly, there was enhanced oxidative stress in the skeletal muscle and development of liver steatosis, inflammation and oxidative protein modifications. Pharmacological inhibition of Nox2 decreased reactive oxygen species production and protein oxidative modifications in the muscle of ApoE-/- mice subjected to a Western-type diet. This study provides key evidence to better understand the pathophysiology of skeletal muscle in the context of hyperlipidaemia and atherosclerosis and identifies Nox2 as a potential target for attenuating oxidative stress in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia.
Animals, Apolipoproteins E/deficiency, Atherosclerosis/drug therapy, Diet, Western/adverse effects, Disease Models, Animal, Enzyme Inhibitors/pharmacology, Gene Expression Regulation, Hyperlipidemias/drug therapy, Hypolipidemic Agents/pharmacology, Lipid Metabolism/drug effects, Liver/drug effects, Male, Metabolome/drug effects, Mice, Mice, Inbred C57BL, Mice, Knockout, Muscle, Skeletal/drug effects, NADPH Oxidase 2/antagonists & inhibitors, Obesity, Oxidation-Reduction, Oxidative Stress/drug effects, Peptides/pharmacology, Reactive Oxygen Species/metabolism, Signal Transduction
504-519
Sfyri, Pagona Panagiota
f307f253-2bb4-47a3-8323-0856cd4101e9
Yuldasheva, Nadira Y.
d08c7562-4bab-4dbd-a96a-fe596dde0065
Tzimou, Anastasia
e001d681-c45c-480c-8576-d74748acfc9b
Giallourou, Natasa
b5891ea7-98d4-49d7-b883-2c57ca2d962a
Crispi, Vassili
3b389ba2-c429-497d-b161-64a628ac53b8
Aburima, Ahmed
54486372-37c9-4d65-9904-54d287735415
Beltran-Alvarez, Pedro
342da99d-2851-4c18-a4f8-4b7faacfd351
Patel, Ketan
b2b42f1a-599d-4747-9246-69379bf6648f
Mougios, Vassilis
a2a7dd04-7c87-4a44-b6ed-1e54a42ce558
Swann, Jonathan R.
7c11a66b-f4b8-4dbf-aa17-ad8b0561b85c
Kearney, Mark T.
f536cadd-e1e5-480f-bd63-3c749e9de2bc
Matsakas, Antonios
9afcce5e-16e6-45a6-8031-1f755cad6a36
December 2018
Sfyri, Pagona Panagiota
f307f253-2bb4-47a3-8323-0856cd4101e9
Yuldasheva, Nadira Y.
d08c7562-4bab-4dbd-a96a-fe596dde0065
Tzimou, Anastasia
e001d681-c45c-480c-8576-d74748acfc9b
Giallourou, Natasa
b5891ea7-98d4-49d7-b883-2c57ca2d962a
Crispi, Vassili
3b389ba2-c429-497d-b161-64a628ac53b8
Aburima, Ahmed
54486372-37c9-4d65-9904-54d287735415
Beltran-Alvarez, Pedro
342da99d-2851-4c18-a4f8-4b7faacfd351
Patel, Ketan
b2b42f1a-599d-4747-9246-69379bf6648f
Mougios, Vassilis
a2a7dd04-7c87-4a44-b6ed-1e54a42ce558
Swann, Jonathan R.
7c11a66b-f4b8-4dbf-aa17-ad8b0561b85c
Kearney, Mark T.
f536cadd-e1e5-480f-bd63-3c749e9de2bc
Matsakas, Antonios
9afcce5e-16e6-45a6-8031-1f755cad6a36
Sfyri, Pagona Panagiota, Yuldasheva, Nadira Y., Tzimou, Anastasia, Giallourou, Natasa, Crispi, Vassili, Aburima, Ahmed, Beltran-Alvarez, Pedro, Patel, Ketan, Mougios, Vassilis, Swann, Jonathan R., Kearney, Mark T. and Matsakas, Antonios
(2018)
Attenuation of oxidative stress-induced lesions in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia and atherosclerosis through the inhibition of Nox2 activity.
Free Radical Biology & Medicine, 129, .
(doi:10.1016/j.freeradbiomed.2018.10.422).
Abstract
Obesity leading to hyperlipidaemia and atherosclerosis is recognised to induce morphological and metabolic changes in many tissues. However, hyperlipidaemia can occur in the absence of obesity. The impact of the latter scenario on skeletal muscle and liver is not understood sufficiently. In this regard, we used the Apolipoprotein E-deficient (ApoE-/-) mouse model, an established model of hyperlipidaemia and atherosclerosis, that does not become obese when subjected to a high-fat diet, to determine the impact of Western-type diet (WD) and ApoE deficiency on skeletal muscle morphological, metabolic and biochemical properties. To establish the potential of therapeutic targets, we further examined the impact of Nox2 pharmacological inhibition on skeletal muscle redox biology. We found ectopic lipid accumulation in skeletal muscle and the liver, and altered skeletal muscle morphology and intramuscular triacylglycerol fatty acid composition. WD and ApoE deficiency had a detrimental impact in muscle metabolome, followed by perturbed gene expression for fatty acid uptake and oxidation. Importantly, there was enhanced oxidative stress in the skeletal muscle and development of liver steatosis, inflammation and oxidative protein modifications. Pharmacological inhibition of Nox2 decreased reactive oxygen species production and protein oxidative modifications in the muscle of ApoE-/- mice subjected to a Western-type diet. This study provides key evidence to better understand the pathophysiology of skeletal muscle in the context of hyperlipidaemia and atherosclerosis and identifies Nox2 as a potential target for attenuating oxidative stress in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia.
This record has no associated files available for download.
More information
Accepted/In Press date: 9 October 2018
e-pub ahead of print date: 17 October 2018
Published date: December 2018
Keywords:
Animals, Apolipoproteins E/deficiency, Atherosclerosis/drug therapy, Diet, Western/adverse effects, Disease Models, Animal, Enzyme Inhibitors/pharmacology, Gene Expression Regulation, Hyperlipidemias/drug therapy, Hypolipidemic Agents/pharmacology, Lipid Metabolism/drug effects, Liver/drug effects, Male, Metabolome/drug effects, Mice, Mice, Inbred C57BL, Mice, Knockout, Muscle, Skeletal/drug effects, NADPH Oxidase 2/antagonists & inhibitors, Obesity, Oxidation-Reduction, Oxidative Stress/drug effects, Peptides/pharmacology, Reactive Oxygen Species/metabolism, Signal Transduction
Identifiers
Local EPrints ID: 440787
URI: http://eprints.soton.ac.uk/id/eprint/440787
ISSN: 0891-5849
PURE UUID: fdbdc66c-8e4e-4f67-b733-9e64bdaf29ce
Catalogue record
Date deposited: 18 May 2020 16:34
Last modified: 17 Mar 2024 04:00
Export record
Altmetrics
Contributors
Author:
Pagona Panagiota Sfyri
Author:
Nadira Y. Yuldasheva
Author:
Anastasia Tzimou
Author:
Natasa Giallourou
Author:
Vassili Crispi
Author:
Ahmed Aburima
Author:
Pedro Beltran-Alvarez
Author:
Ketan Patel
Author:
Vassilis Mougios
Author:
Mark T. Kearney
Author:
Antonios Matsakas
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics